Search
for
Sort by
Research 601–630 of 1000+
- Mechanism-Based Inhibition of Human Steroid 5α-Reductase by Finasteride: Enzyme-Catalyzed Formation of NADP−Dihydrofinasteride, a Potent Bisubstrate Analog Inhibitor
- Structure of human type II 5 alpha-reductase gene.
- Guideline for the primary care management of male lower urinary tract symptoms
- Clinical Pharmacokinetics and Pharmacodynamics of Finasteride
- Critical Analysis on Characterization, Systemic Effect, and Therapeutic Potential of Beta-Sitosterol: A Plant-Derived Orphan Phytosterol
- Comparison of Finasteride (Proscar®) and Serenoa repens (Permixon®) in the Inhibition of 5-Alpha Reductase in Healthy Male Volunteers
- Steroid 5α-Reductase as a Novel Therapeutic Target for Schizophrenia and Other Neuropsychiatric Disorders
- Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation
- Anti-androgenic activities of Ganoderma lucidum
- Combined Sabal and Urtica extract vs finasteride in BPH (Alken stage I–II)
- A Randomized, Double-Blind, Placebo-Controlled Trial to Determine the Effectiveness of Botanically Derived Inhibitors of 5-<i>α</i>-Reductase in the Treatment of Androgenetic Alopecia
- Anti-androgenic activities of the triterpenoids fraction of Ganoderma lucidum
- A model for the turnover of dihydrotestosterone in the presence of the irreversible 5α-reductase inhibitors GI198745 and finasteride
- Discovery and Clinical Development of Dutasteride, a Potent Dual 5α- Reductase Inhibitor
- Effect of 5α-Reductase Inhibitors on Sexual Function: A Meta-Analysis and Systematic Review of Randomized Controlled Trials
- Effects of the 5α-Reductase Inhibitor Finasteride on Serum Levels of Gonadal, Adrenal, and Hypophyseal Hormones and its Clinical Significance: A Prospective Clinical Study
- Significance of the polyglutamine tract polymorphism in the androgen receptor
- A Comparison of Varying alpha-Blockers and Other Pharmacotherapy Options for Lower Urinary Tract Symptoms.
- Intraoperative floppy-iris syndrome and finasteride intake
- Selective non-steroidal inhibitors of 5α-reductase type 1
- Potency of a novel saw palmetto ethanol extract, SPET-085, for inhibition of 5α-reductase II
- Acute urinary retention: risks and management.
- Clinical application of 5α-reductase inhibitors
- 5α-Reductases In Human Physiology: an Unfolding Story
- Anti-androgenic effect of sesquiterpenes isolated from the rhizomes of Curcuma aeruginosa Roxb.
- PNU 157706, a novel dual type I and II5α-reductase inhibitor
- Effect of finasteride and/or terazosin on serum PSA: Results of VA cooperative study #359
- Finasteride
- Finasteride and sexual side effects
- Doping-Control Analysis of the 5α-Reductase Inhibitor Finasteride: Determination of Its Influence on Urinary Steroid Profiles and Detection of Its Major Urinary Metabolite